Kevin Czerney - 11 Apr 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
VP, Chief Accounting Officer
Signature
/s/ Lindi Barton-Brobst, Attorney-In-Fact for Kevin Czerney
Issuer symbol
XRAY
Transactions as of
11 Apr 2025
Net transactions value
+$584
Form type
4
Filing time
15 Apr 2025, 16:05:09 UTC
Previous filing
28 Mar 2025
Next filing
15 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +202 +0.76% $0.000000 26,719 11 Apr 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Award $532 +43 +1.3% $12.47 3,370 11 Apr 2025 Common Stock 43 Direct F3, F4
transaction XRAY Phantom Stock (Dentsply Supplemental Savings Plan) DSSP Award $52.05 +4 +1.3% $12.47 329 11 Apr 2025 Common Stock 4 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2 Includes 90.964 shares acquired through dividend reinvestment on 4/10/2025.
F3 Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.
F4 Comprised of phantom stock acquired as a result of accrued dividends.